Replimune Group, Inc. ( REPL) - Stock Earnings
REPL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
REPL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -70.9 million USD | — USD |
| 2026Q1 | -73.2 million USD | — USD |
| 2026Q2 | -69.8 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
REPL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -215.8 million USD | — USD |
| 2025 | -247.3 million USD | — USD |
| 2026 | -313.9 million USD | — USD |
| 2026 Est. | — | — |
REPL
Price: $11.75
52 week price:
Earnings Per Share: -3.15 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 354500
Market Capitalization: 1.1 billion